Three Rare Cases of Pulmonary Squamous Cell Carcinoma Harboring a KRAS Mutation, Including the Actionable G12C Variant
Pathology International · 2026-07 · 76 (7)
DOI: 10.1111/pin.70148 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, online erschienen am 17.07.2026. Verfasst von Daiji Ohba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koutou-ward, Tokyo, Japan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Lung Neoplasms, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Koutou-ward, Tokyo, Japan.
- Department of Thoracic and Cardiovascular Surgery, Saga University, Saga, Japan.
- Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koutou-ward, Tokyo, Japan.
ORCID-Profile: Hironori Ninomiya
Zitieren
APA
Ohba, D., Hiratsuka, M., & Ninomiya, H. (2026). Three Rare Cases of Pulmonary Squamous Cell Carcinoma Harboring a KRAS Mutation, Including the Actionable G12C Variant. Pathology International, 76(7). https://doi.org/10.1111/pin.70148
Vancouver
Ohba D, Hiratsuka M, Ninomiya H. Three Rare Cases of Pulmonary Squamous Cell Carcinoma Harboring a KRAS Mutation, Including the Actionable G12C Variant. Pathology International. 2026;76(7). doi:10.1111/pin.70148
BibTeX
@article{Ohba2026,
author = {Ohba, Daiji and Hiratsuka, Masafumi and Ninomiya, Hironori},
title = {Three Rare Cases of Pulmonary Squamous Cell Carcinoma Harboring a KRAS Mutation, Including the Actionable G12C Variant},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {7},
doi = {10.1111/pin.70148}
}
EUVIMED